Rapid Micro Biosystems Q1 revenue up 11% to $8.0M; net loss widens to $14.3M

RAPID MICRO BIOSYSTEMS, INC.

Total revenue $8.0M (+11% YoY); product revenue $5.6M (+36%).
Net loss $14.3M ($0.31/sh) vs $11.3M ($0.26/sh) in Q1 2025.
Recurring revenue $5.1M (+28%), 63% of total; placed 6 Growth Direct systems (3 in Q1 2025).
Gross margin 4.6% vs 5.6% last year; cash and equivalents $23M.
Reaffirms FY2026 guidance: revenue $37-41M, 30-38 system placements, ~20% gross margin.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.